Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$19.15 – $41.61
47% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $7.40T | $6.83T | $6.33T | $8.51T | $9.19T | $7.25T | $7.79T | $8.32T |
| Cost of revenue | $6.67T | $6.13T | $6.13T | $5.66T | $8.14T | $6.18T | $6.64T | $7.13T |
| Gross profit | $729.67B | $696.81B | $696.81B | $911.00B | $1.05T | $1.07T | $1.15T | $1.19T |
| Gross margin | 9.9% | 10.2% | 11.0% | 10.7% | 11.4% | 14.7% | 14.7% | 14.3% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | −$41.92B | −$48.72B | $162.34B | $300.16B | $384.18B | $276.32B | $272.31B | $258.29B |
| EBITDA | $449.17B | $48.72B | $249.61B | $383.68B | $478.72B | $429.44B | $908.90B | $953.04B |
| Net income | $230.89B | −$197.45B | $223.26B | $424.32B | $543.00B | $471.41B | $502.96B | $547.28B |
| Net margin | 3.1% | -2.9% | 3.5% | 5.0% | 5.9% | 6.5% | 6.5% | 6.6% |
| EPS (diluted) | 132.94 | -113.77 | 126.17 | 242.44 | 315.58 | 279.24 | 302.51 | 332.34 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2027 | $8.69T | $374.03 | $341.65–$431.04 | 1 |
| 2028 | $8.87T | $392.40 | $358.42–$452.21 | 1 |
| 2029 | $8.96T | $421.27 | $384.79–$485.48 | 1 |
| 2030 | $10.11T | $435.57 | $397.85–$501.95 | 1 |
Forward consensus · source: Financial Modeling Prep
MARUBENI CORP ORD
No one on the platform currently holds MARUF.
No tracked institution reports a position in MARUF as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2027-03-31 | $57.5000 | |
| 2026-09-30 | $57.5000 | |
| 2026-03-31 | $57.5000 | 2026-06-01 |
| 2025-09-30 | $50.0000 | 2025-12-01 |
| 2025-03-31 | $50.0000 | 2025-06-02 |
| 2024-09-30 | $45.0000 | 2024-12-02 |
| 2024-03-28 | $43.5000 | 2024-06-03 |
| 2023-09-29 | $41.5000 | 2023-12-01 |
No one on the platform has traded MARUF yet.
| $39.3B |
| — |
| CTPCYCITIC Limited | $7.50 | -1.32% | $43.6B | — |
| SDVKYSandvik AB (publ) | $40.32 | +1.87% | $50.6B | — |
Source: Financial Modeling Prep · peers by sector/industry
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
Trading at 0.1× earnings vs its 0.1× historical median P/E.
Fair value ≈ $18.34 · price $29.70 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.